Clinical trial
Phase IIIB Switching From Intravenous to Subcutaneous Study
NCT00663702
Study timeline
Study start (unknown)2008-05-01Date precision: month
Registry last updated2015-03-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Arthritis, Rheumatoidunresolved
Interventions
AbataceptDRUG · verified · RxNorm: abatacept
Sponsors & collaborators
Bristol-Myers Squibblead sponsor
Mapped research locations
Mexico CityMexico City, Mexico2DallasTexas, United States1TorontoOntario, Canada1CincinnatiOhio, United States1MontrealQuebec, Canada1IndianapolisIndiana, United States1AustinTexas, United States1Las VegasNevada, United States1CharlotteNorth Carolina, United States1La JollaCalifornia, United States1Long BeachCalifornia, United States1EdmontonAlberta, Canada1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00663702 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.